Bank of New York Mellon Corp Takes Position in Humana Inc. $HUM

Bank of New York Mellon Corp purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 599,527 shares of the insurance provider's stock, valued at approximately $238,144,000. Bank of New York Mellon Corp owned 0.50% of Humana at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Focus Partners Advisor Solutions LLC bought a new position in shares of Humana in the second quarter worth approximately $314,000. State of Wyoming bought a new position in shares of Humana during the second quarter valued at about $95,000. S&CO Inc. purchased a new stake in shares of Humana during the second quarter worth about $2,919,000. Bridgewater Advisors Inc. purchased a new stake in shares of Humana during the second quarter worth about $310,000. Finally, Oppenheimer Asset Management Inc. bought a new stake in shares of Humana in the second quarter worth about $9,054,000. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on HUM shares. Robert W. Baird set a $390.00 price target on Humana in a research report on Thursday, July 30th. TD Cowen boosted their target price on Humana from $350.00 to $370.00 and gave the company a "hold" rating in a research note on Friday, July 31st. HSBC downgraded Humana to a "hold" rating in a report on Thursday, July 30th. UBS Group initiated coverage on Humana in a research note on Thursday, July 30th. They issued a "buy" rating for the company. Finally, Jefferies Financial Group upgraded shares of Humana from a "buy" rating to a "buy" rating in a report on Wednesday, May 20th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $395.22.

Humana Stock Performance

Shares of HUM stock opened at $379.22 on Friday. The company has a market capitalization of $45.54 billion, a price-to-earnings ratio of 35.88, a price-to-earnings-growth ratio of 2.17 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company's 50-day moving average is $383.38 and its 200 day moving average is $281.59.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm had revenue of $40.89 billion for the quarter, compared to analysts' expectations of $40.58 billion. During the same quarter in the prior year, the company posted $6.27 earnings per share. The business's revenue for the quarter was up 26.2% on a year-over-year basis. Sell-side analysts expect that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source